Suicidal behavior in schizophrenia

Expert Review of Neurotherapeutics

Volumn 5, Issue 1, 2005, Pages 95-99

  Tandon, Rajiv ^a  

^a Department of Children and Families   (United States)

Author keywords

Antipsychotic; Atypical antipsychotic; Clozapine; Depression; Epidemiology; Pathophysiology schizophrenia; Substance abuse; Suicide

Indexed keywords

CLOZAPINE; LITHIUM CHLORIDE; OLANZAPINE;

BIPOLAR DEPRESSION; CLINICAL FEATURE; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL ASSESSMENT; NEUROBIOLOGY; OBESITY; PSYCHOLOGIC ASSESSMENT; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT INDICATION; WEIGHT GAIN;

EXPERT TESTIMONY; HUMANS; NEUROBIOLOGY; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF-INJURIOUS BEHAVIOR; SUICIDE;

EID: 12344306130     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.5.1.95     Document Type: Review

References (70)

1. Tandon R, Jibson MD, Glick ID et al. Treating Schizophrenia: a Primer 2005. McMahon Publishing, NY, USA (2004).
2. Babidge NC, Buhrich N, Butler T. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psych. Scand. 103, 105-110 (2001).
3. Ran M, Xiang M, Huang M, Shan Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. Br. J. Psychiatry 178, 154-158 (2001).
4. Osby U, Correia N, Brandt L et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr. Res. 45, 21-28 (2000).
5. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br. J. Psychiatry 177, 212-217 (2000).
6. Bralet MC, Yon V, Loas G, Noisette C. Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients. Encephale 26, 32-41 (2000).
7. Le Fevre PD. Improving the physical health of patients with schizophrenia: therapeutic nihilism or realism? Scott Med. J. 46, 11-13 (2001).
8. Nordentoft M, Jeppesen P, Abel M et al. OPUS study: suicidal behavior, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomized controlled trial. Br. J. Psychiatry 181(Suppl. 43), S98-S106 (2002).
9. Barak Y, Knobler CY, Aizenberg D. Suicide attempts amongst elderly schizophrenia patients: a 10-year case-control study. Schizophr. Res. 71, 77-81 (2004).
10. Coman M, Meyer AD, Cameron PA. Jumping from the Westgate Bridge, Melbourne. Med. J. Aust. 172, 67-69 (2000).
11. Martin BA. The Clarke Institute experience with completed suicide: 1966 to 1997. Can. J. Psychiatry 45, 630-638 (2000).
12. Deisenhammer EA, DeCol C, Honeder M et al. In-patient suicide in psychiatric hospitals. Acta Psych. Scand. 102, 290-294 (2000).
13. Ostroglazov VG, Lisina MA. Clinico-psychopathological characteristics of states in patients with suicidal attempts. Zh. Nevrol. Psikhiatr. Im. S S Korsakova 100, 18-20 (2000).
14. Kreyenbuhl JA, Kelly DL, Conley RR. Circumstances of suicide among individuals with schizophrenia. Schizophr. Res. 58, 253-261 (2002).
15. Heila H, Isometsa ET, Henriksson MM et al. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex- specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry 154, 1235-1242 (1997).
16. Bhatia MS, Aggarwal NK, Aggarwal BB. Psychosocial profile of suicide ideators, attempters and completers in India. Int. J. Soc. Psychiatry 46, 155-163 (2000).
17. Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol. Med. 31, 837-845 (2001).
18. Krupinski M, Fischer A, Grohmann R et al. Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment. Nervenarzt 71, 906-911 (2000).
19. Schwartz RC, Cohen BN. Psychosocial correlates of suicidal intent among patients with schizophrenia. Com. Psychiatry 42, 118-123 (2001).
20. De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr. Res. 47, 127-134 (2001). Excellent case-control study of suicide in schizophrenia.
21. Siris SG. Suicide and schizophrenia. J. Psychopharmacol. 15, 127-135 (2001). Comprehensive review of the role of depression in relation to suicide in schizophrenia.
22. Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr. Res. 58, 213-220 (2002).
23. Harkavy-Friedman JM, Restifo K, Malaspina D et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am. J. Psychiatry 156, 1276-1278 (1999).
24. Goodwin R, Davidson L. Panic attacks in psychosis. Acta Psychiatr. Scand. 105, 14-19 (2002).
25. Grunebaum MF, Oquendo MA, Harkavy-Friedman JM et al. Delusions and suicidality. Am. J. Psychiatry 158, 742-747 (2001).
26. Messias E, Kirkpatrick B, Ram R, Tien AY. Suspiciousness as a specific risk factor for major depressive episodes in schizophrenia. Schizophr. Res. 47, 159-165 (2001).
27. Kontaxakis V, Havaki-Kontaxaki B, Margariti M et al. Suicidal ideation in inpatients with acute schizophrenia. Can. J. Psychiatry 49, 476-479 (2004).
28. Tapp A, Kilzieh N, Wood AE et al. Depression in patients with schizophrenia during an acute psychotic episode. Comp. Psychiatry 42, 314-318 (2001).
29. Marengo J, Harrow M, Herbener ES, Sands J. A prospective longitudinal 10-year study of schizophrenia's three major factors and depression. Psychiatry Res. 97, 61-77 (2000).
30. Muller MJ, Szegedi A, Wetzel H, Benkert O. Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr. Bull. 27, 19-28 (2001).
31. Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br. J. Psychiatry 177, 522-528 (2000).
32. Delahanty J, Ram R, Postrada L et al. Differences in rates of depression in schizophrenia by race. Schizophr. Bull. 27, 29-38 (2001).
33. Siris SG. Depression in schizophrenia. Perspective in the era of 'atypical' antipsychotic agents. Am. J. Psychiatry 157, 1379-1389 (2000).
34. Hausmann A, Fleischhacker WW. Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatr. Scand. 106, 83-96 (2002). Systematic approach to the assessment and treatment of depression in schizophrenia.
35. Kamali M, Kelly L, Gervin M et al. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr. Scand. 101, 452-456 (2000).
36. Gut-Fayand A, Dervaux A, Olie JP et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res. 102, 65-72 (2001). Studies the relationship of substance abuse and impulsivity with suicide in schizophrenia.
37. Dassori AM, Mezzich JE, Keshavan MS. Suicidal indicators in schizophrenia. Acta Psychiatr. Scand. 81, 409-413 (1990).
38. Schwartz RC. Insight and suicidality in schizophrenia: a replication study. J. Nerv. Ment. Dis. 188, 235-237 (2000).
39. Schwartz RC. Self-awareness in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments. J. Nerv. Ment. Dis. 189, 401-403 (2001).
40. Atbasoglu EC, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depeisonalization among patients with schizophrenia. J. Neuropsychiatry Clin. Neurosci. 13, 336-341 (2001). Studies the role of akathisia in suicidality in schizophrenia.
41. Hansen L. A critical review of akathisia, and its possible association with suicidal behavior. Human Psychopharmacol. 16, 495-505 (2001).
42. Caberlotto L, Hurd YL. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 25, 91-97 (2001).
43. 2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24, 478-491 (2001).
44. Brunner J, Stalla GK, Stalla J et al. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J. Psych. Res. 35, 1-9 (2001).
45. Nolan KA, Volavka J, Czobor P et al. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr Gene. 10, 117-124 (2000).
46. Bergquist J, Traskman-Bendz L, Lindstrom MB, Ekman R. Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. Eur. Neuropsychopharmacol. 12, 153-158 (2002).
47. Filipovic B, Teofilovski-Parapid G, Stojicic M. Comparative post-mortem study of cavum septi pellucidi in alcoholics, schizophrenics and aggressive persons. Folia Morphol. 58, 297-305 (2000).
48. Chong SA, Lee WL, Tan CH et al. Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res. 97, 101-106 (2000).
49. Tan EC, Chong SA, Chan AOM, Tan CH. No evidence for association of the T102C polymorphism in the serotonin 2A receptor with suicidal behavior in schizophrenia. Am. J. Med. Genet. 114, 321-322 (2002).
50. Huang T, Wu S. Serum cholesterol levels in paranoid and non-paranoid schizophrenia associated with physical violence or suicide attempts in Taiwanese. Psychiatry Res. 96, 175-178 (2000).
51. Rajarethinam RP, DeQuardo JR, Brunberg J, Tandon R. Cavum septum pellucidum in schizophrenia: prevalence and implications. Schizophr. Res. 48, 201-205 (2001).
52. Lewis C, DeQuardo JR, Tandon R. Biological predictors of suicidality in schizophrenia. Acta Psych. Scand. 44, 416-420 (1996).
53. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24, 467-477 (2001).
54. Correa H, Duval F, Mokrani MC et al. Serotonergic function and suicidal behavior in schizophrenia. Schizophr. Res. 56, 75-85 (2002). Addresses the role of serotonergic abnormalities in mediating suicidal behavior in schizophrenia.
55. Meltzer HY. Treatment of suicidality in schizophrenia. Ann. NY Acad. Sci. 932, 44-60 (2001).
56. Ciapparelli A, Dell'Osso L, Pini S et al. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder. a 24-month naturalistic study. J. Clin. Psychiatry 61, 329-334 (2000).
57. Meltzer HY, Alphs L, Altamura AC et al. International Suicide Prevention Trial (InterSePT): reduced suicidality in schizophrenia with clozapine treatment. Arch. Gen. Psych. 59, 82-91 (2003). Excellent study of the pharmacologic treatment of suicidality in schizophrenic illness, comparing clozapine with olanzapine.
58. Tamam L, Ozpoyraz N. Suicide during clozapine treatment: a case report. Isr. J. Psychiatry Rel. Sci. 38, 127-132 (2001).
59. Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on completed suicide. Am. J. Psychiatry 158, 931-937 (2001).
60. Peuskens J, Van Baelen B, De Smedt C, Lemmens P. Effect of risperidone on affective symptoms in patients with schizophrenia. Int. Clin. Psychopharmacol. 15, 343-349 (2000).
61. Keck PE Jr, Strakowski SM, McElroy SL. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J. Clin. Psychiatry 61 (Suppl. 3), 4-9 (2000).
62. Aleman A, Kahn RS. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. Eur. Neuropsychopharmacol. 11, 289-293 (2001).
63. Chakos M, Lieberman J, Hoffman E et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia. Am. J. Psychiatry 158, 518-526 (2001).
64. Jibson MD, Tandon R. Treatment of schizophrenia. Psych. Clin. N. Am. Ann. Drug Ther. 7, 83-113 (2000).
65. Barak Y, Mirecki I, Knobler HY et al. Suicidality and second-generation antipsychotics in schizophrenia patients. Psychopharmacology 175, 215-219 (2004).
66. Khan A, Khan SR, Lenthal RM, Brown WA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am. J. Psychiatry 158, 1449-1454 (2001).
67. Cunningham Owens DG, Carroll A, Fattah S et al. A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatr. Scand. 103, 362-369 (2001).
68. Burgess P, Pirkis J, Morton J, Croke E. Lessons from a comprehensive clinical audit of users of psychiatric services who committed suicide. Psychiatr. Serv. 51, 1555-1560 (2000).
69. Taiminen T, Huttunen J, Heila H et al. The Schizophrenia Suicide Risk Scale. Schizophr. Res. 47, 199-213 (2001).
70. Bleuler E. Dementia Praecox or the Group of Schizophrenias. IU Press, NY, USA, 488 (1950).